Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China · Delayed Price · Currency is CNY 7.90
+0.08 (1.02%)
May 20, 2026, 3:00 PM CST
SHA:600222 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 61.07 | 60 | 50.53 | 43.56 | -72.2 | 6 |
Depreciation & Amortization | 63.85 | 63.85 | 64.94 | 67.93 | 62.98 | 57.18 |
Other Amortization | 9.28 | 9.28 | 8.38 | 7.77 | 4.95 | 3.31 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | -0.13 | -0.62 | -0.07 | - |
Asset Writedown & Restructuring Costs | 0.13 | 0.13 | -0 | 0.08 | -0.1 | 1.57 |
Loss (Gain) From Sale of Investments | -1.24 | -1.24 | -10.67 | 6.42 | 11.87 | 6.52 |
Provision & Write-off of Bad Debts | 17.48 | 17.48 | 7.09 | 11.86 | 33.81 | 25.54 |
Other Operating Activities | -134.41 | 75.26 | 57.16 | 47.22 | 65.17 | 91.74 |
Change in Accounts Receivable | -218.71 | -218.71 | -91.32 | -3.07 | -380.27 | -130.93 |
Change in Inventory | 9.94 | 9.94 | 91.06 | -7.38 | -70.61 | -37.3 |
Change in Accounts Payable | 23.22 | 23.22 | -196.56 | -123.27 | 231.57 | 82.8 |
Operating Cash Flow | -161.45 | 47.16 | -39.59 | 43.74 | -124.41 | 99.66 |
Operating Cash Flow Growth | - | - | - | - | - | 35.72% |
Capital Expenditures | -19.84 | -21.12 | -37.23 | -43.13 | -66.62 | -39.07 |
Sale of Property, Plant & Equipment | -0.01 | 0.07 | 0.17 | 0.22 | 0.19 | 0.06 |
Divestitures | 0.09 | 0.09 | - | 1.8 | 0.2 | 0.57 |
Investment in Securities | 6.62 | -17.67 | 49.44 | -164 | 137.25 | -87.67 |
Other Investing Activities | 20.77 | 38.8 | 5.88 | 55.1 | 63.1 | 25.96 |
Investing Cash Flow | 7.63 | 0.16 | 18.25 | -150.02 | 134.12 | -100.16 |
Short-Term Debt Issued | - | 400 | - | - | - | - |
Long-Term Debt Issued | - | 1,481 | 1,368 | 1,076 | 950.09 | 1,298 |
Total Debt Issued | 2,117 | 1,881 | 1,368 | 1,076 | 950.09 | 1,298 |
Long-Term Debt Repaid | - | -1,688 | -1,264 | -938.41 | -1,403 | -1,381 |
Net Debt Issued (Repaid) | 373.07 | 193.71 | 103.77 | 137.3 | -452.6 | -82.27 |
Issuance of Common Stock | 41.26 | 41.26 | 0.06 | 34.46 | 137.17 | 95.16 |
Repurchase of Common Stock | -8.79 | -8.79 | -21.28 | -42.07 | -37.66 | -45.48 |
Common Dividends Paid | -59.27 | -50.76 | -69.07 | -50.17 | -63.51 | -84.56 |
Other Financing Activities | -431.24 | -190.78 | -23.26 | -52.97 | 331.37 | -39.44 |
Financing Cash Flow | -84.96 | -15.37 | -9.78 | 26.56 | -85.23 | -156.58 |
Net Cash Flow | -238.78 | 31.95 | -31.11 | -79.72 | -75.51 | -157.08 |
Free Cash Flow | -181.28 | 26.04 | -76.82 | 0.6 | -191.03 | 60.58 |
Free Cash Flow Growth | - | - | - | - | - | 7717.75% |
Free Cash Flow Margin | -10.16% | 1.48% | -3.96% | 0.03% | -9.74% | 3.78% |
Free Cash Flow Per Share | -0.33 | 0.05 | -0.14 | 0.00 | -0.34 | 0.11 |
Cash Interest Paid | 1.11 | 1.11 | 1.6 | 0.8 | 3.73 | 4.54 |
Cash Income Tax Paid | 79.37 | 70.65 | 59.03 | 84.4 | 59.53 | 51 |
Levered Free Cash Flow | -129.23 | 303.75 | -285.12 | -99.01 | 361.28 | 127.37 |
Unlevered Free Cash Flow | -94.04 | 338.95 | -247.84 | -65.03 | 401.67 | 179.77 |
Change in Working Capital | -177.63 | -177.63 | -216.88 | -140.48 | -230.82 | -92.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.